Zhiyuan Zhang

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 09, 2026
Short-Course Radiotherapy Combined With CapeOx and PD-1 Inhibitor Following Local Excision in High-Risk Early Rectal Cancer: Study Protocol for a Prospective Phase II Trial (TORCH-LE).

|Jul 25, 2025
Long-Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer.

Siyuan Chen, Ruiyan Wu, Juefeng Wan

|May 12, 2025
Total neoadjuvant therapy in high-risk rectal cancer: organ preservation and survival outcomes in a single-center retrospective cohort.

Zhiyuan Zhang, Ruiyan Wu, Zhenyu Ke

|Jul 01, 2024
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).

Fan Xia, Yaqi Wang, Hui Wang

|Jun 26, 2024
Radiomic score for lung nodules as a prognostic biomarker in locally advanced rectal cancer patients: A bi-institutional study.

Zhiyuan Zhang, Jiazhou Wang, Di Dai

Pageof 1

Frequent Collaborators

3 joint publications

Zhen Zhang

2 joint publications

Yaqi Wang

2 joint publications

Jingwen Wang

2 joint publications

Ye Xu